PepGen Inc.
NASDAQ:PEPG · NASDAQ Global Select
+$0.09 today
Vol 0.69M · Avg 1.37M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+28.78%
Period High
$7.17
Period Low
$1.01
Latest
$1.79
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cybin Inc.
CYBN
$413.02M
Fate Therapeutics, Inc.
NASDAQ:FATE
$231.95M
Nkarta, Inc.
NASDAQ:NKTX
$194.96M
Alector, Inc.
NASDAQ:ALEC
$182.08M
Molecular Partners AG
NASDAQ:MOLN
$147.61M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$102.48M
Cardiff Oncology, Inc.
NASDAQ:CRDF
$82.04M
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$73.03M
Cassava Sciences, Inc.
SAVA
$63.77M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest PEPG filing?
The latest filing shown is 4 dated May 26, 2026.
How many recent filings does PEPG have?
Intrinsic Alpha currently shows 20 recent filings for PEPG.
Explore More
Continue the stock analysis
Jump to another research area for this company.